Ascendis spins out ophthalmology company; Gamida Cell eyes strategic options

Plus, news about Skye Bioscience and Vera Therapeutics:

Ascendis Pharma, investors spin out eye care company: Eyconis, based in Redwood City, CA, will develop, manufacture and commercialize the company’s ophthalmology assets, as previously disclosed. The investor group includes Frazier Life Sciences, RA Capital Management, venBio and…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Advertisement — Advertise with Biotech Networks